Pressure BioSciences Posts 69 Percent Revenue Increase for Q1 but Warns of Pressing Need for Cash | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences today reported revenues increased 69 percent year over year during its first quarter, paced by grants-related revenue.

In a document filed with the US Securities and Exchange Commission, however, the company warned that it will need to secure funds or faces the possibility of shutting its doors after the end of the month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.